Cilostazol
Links shared publicly online about this topic
Cilostazol could cut repeat stroke rate | Healthcare Republic
healthcarerepublic.com — “Cilostazol could cut repeat stroke rate | Healthcare Republic” View full resource at healthcarerepublic.com
Most Recently Shared on September 13, 2010 at 1:25 pm By:
Cilostazol could cut repeat stroke rate: Using cilostazol, rather than aspirin, to prevent repeat stroke is associ... http://bit.ly/csZ8th
Peripheral arterial disease - cilostazol, naftidrofyryl oxalate, pentoxifylline and inositol nicotinate
guidance.nice.org.uk — “Peripheral arterial disease - cilostazol, naftidrofyryl oxalate, pentoxifylline and inositol nicotinate” View full resource at guidance.nice.org.uk
Most Recently Shared on May 25, 2011 at 10:13 am By:
New NICE guidance on PAD recommends naftidrofuryl oxalate but not cilostazol, pentoxifylline or inositol nicotinate: http://bit.ly/jXBAX0
Reuters AlertNet - Cilostazol may prevent secondary stroke in Asians
alertnet.org — “Source: Reuters HONG KONG, Sept 11 (Reuters) - The anti-clotting drug cilostazol may work better than aspirin in preventing secondary stroke in east Asian patients, a study in Japan has found. In a paper published...” View full resource at alertnet.org
Most Recently Shared on September 11, 2010 at 7:16 am By:
Cilostazol may prevent secondary stroke in Asians: Source: Reuters HONG KONG, Sept 11 (Reuters) - The anti-clottin... http://bit.ly/9sEDWR
Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?
hindawi.com — “Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of patients undergoing coronary stenting. Clopidogrel has mostly replaced the use of ticlopidine due to its more favourable adverse event profile. However, also the use of clopidogrel is not without side effects. Clopidogrel major adverse events are represented by marrow suppression, manifesting with aplastic anaemia, thrombocytopenia and neutropenia. When clopidogrel toxicity occurs, there are few and ” View full resource at hindawi.com
Most Recently Shared on August 11, 2011 at 5:48 pm By:
Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?: We report a case of ... http://bit.ly/qZmVOm
Medical News: Second Strokes Less Common With Cilostazol - in Cardiovascular, Strokes from MedPage Today
medpagetoday.com — “The antiplatelet agent cilostazol (Pletal) appeared significantly more effective than aspirin for secondary prevention of strokes and was associated with fewer major bleeding events in a Japanese stud” View full resource at medpagetoday.com
Most Recently Shared on September 11, 2010 at 1:20 pm By:
Second Strokes Less Common With Cilostazol (CME/CE): (MedPage Today) -- The antiplatelet agent cilostazol (Pletal)... http://bit.ly/alxk1M
Second Strokes Less Common With Cilostazol (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The antiplatelet agent cilostazol (Pletal) appeared significantly more effective than aspirin for secondary prevention of strokes and was associated with fewer major bleeding events in a Japanese study.” View full resource at qualitypointtech.net
Most Recently Shared on September 10, 2010 at 11:12 pm By:
Second Strokes Less Common With Cilostazol (CME/CE): (MedPage Today) -- The antiplatelet agent cilostazol (Pletal)... http://bit.ly/bod0CF
The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes… - Tom Heston
tomheston.com — “The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes… - Tom Heston” View full resource at tomheston.com
Most Recently Shared on August 18, 2010 at 8:26 pm By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects... http://bit.ly/9P1X7n
Cilostazol versus aspirin for secondary prevention... [Cochrane Database Syst Rev. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on February 3, 2011 at 12:48 am By:
Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin.: Authors:... http://bit.ly/fkMP3l
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial : The Lancet Neurology
thelancet.com — “Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. By - Prof Yukito Shinohara MD, Prof Yasuo Katayama MD, Prof Shinichiro...” View full resource at thelancet.com
Most Recently Shared on September 13, 2010 at 1:22 pm By:
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non ...: T... http://bit.ly/c8G23N
ESC> Communities> ESC Councils> Council for Cardiology Practice> E-journal of Cardiology Practice> E-Journal volume 8> Peripheral arterial disease : Role of cilostazol
escardio.org — “ESC> Communities> ESC Councils> Council for Cardiology Practice> E-journal of Cardiology Practice> E-Journal volume 8> Peripheral arterial disease : Role of cilostazol” View full resource at escardio.org
Most Recently Shared on September 21, 2009 at 11:03 am By:
European Cardiology Cardiology and Medical Society
Peripheral arterial disease : Role of cilostazol http://tinyurl.com/ml6jah #fb
Triple antiplatelet therapy after PCI
theheart.org — “Adding cilostazol to clopidogrel and aspirin did not significantly reduce event rates, but it did improve posttreatment platelet reactivity in the CILON-T trial, and the study was underpowered for hard clinical events.” View full resource at theheart.org
Most Recently Shared on March 16, 2010 at 3:49 pm By:
Is triple antiplatelet therapy after PCI the way forward?: Adding cilostazol to clopidogrel and aspirin did ... http://bit.ly/ctWuXC #ACC10
Current Blood Thinners Face Tough Competition - Drugs.com MedNews
drugs.com — “New studies provide more proof that the mainstays of anti-clotting therapy, namely warfarin and aspirin, are facing some severe competition from newcomers. Rese” View full resource at drugs.com
Most Recently Shared on February 28, 2010 at 4:19 am By:
Current Blood Thinners Face Tough Competition - http://bit.ly/cIpleW
Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events : The Lancet Neurology
thelancet.com — “Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events. By - Graeme J Hankey FRACP, John W Eikelboom FRACP” View full resource at thelancet.com
Most Recently Shared on February 26, 2010 at 12:19 am By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Antithrombotic drugs to treat TIA and ischemic stroke - http://bit.ly/cmBc6n
Medical News: ASA: Antiplatelet Tops Aspirin for Secondary Stroke Prevention - in Meeting Coverage, ASA from MedPage Today
medpagetoday.com — “Cilostazol, an antiplatelet agent used in the U.S. to treat intermittent claudication, was better than aspirin at preventing recurrent stroke from noncardiogenic sources, a randomized trial conducted” View full resource at medpagetoday.com
Most Recently Shared on February 26, 2010 at 9:07 pm By:
ASA: Antiplatelet Tops Aspirin for Secondary Stroke Prevention (CME/CE) Cilostazol, an antiplatelet agent used in the.. http://bit.ly/9I8oWJ
Cardiology Medical News about Intermittent Claudication
mdlinx.com — “A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication” View full resource at mdlinx.com
Most Recently Shared on May 21, 2010 at 8:15 pm By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
A pooled analysis of the durability and predictors of treatment response of cilostazol in patients ... http://bit.ly/cHNGOl #cardio #mdlinx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Stroke OW
Organizing stroke and mini-stroke resources shared by health experts, advocates, and organizations into WisdomCards.
-
MIMS Online
MIMS is the print and online prescribing database for all healthcare professionals.
-
Stroke OW
Organizing stroke and mini-stroke resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
